Statins: A case for drug withdrawal in patients with dementia

Journal of the American Geriatrics Society

Volumn 58, Issue 6, 2010, Pages 1214-1216

  Padala, Kalpana P ^a   Padala, Prasad R ^a,b   Potter, Jane F ^c  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b VA NEBRASKA WESTERN IOWA HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; DONEPEZIL; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;

AGED; ANTIINFLAMMATORY ACTIVITY; CLINICAL ARTICLE; COGNITION; DATA ANALYSIS; DEMENTIA; DRUG MECHANISM; DRUG USE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GERIATRIC ASSESSMENT; HUMAN; LETTER; MALE; MEDICAL RECORD REVIEW; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; RELIABILITY; STUDENT T TEST; DRUG EFFECTS; RETROSPECTIVE STUDY; RISK FACTOR;

AGED; COGNITION; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 77953097623     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2010.02889.x     Document Type: Letter

References (10)

1. LaRosa JC, He J, Vupputuri S. Effect of statins on risk of coronary disease: A meta-analysis of randomized controlled trials. JAMA 1999 22-29; 282:2340-2346. Summary for patients in: J Am Geriatr Soc 2002; 50:391-393.
2. Thompson PD, Clarkson P, Karas RH. Statin-associated myopathy. JAMA 2003 289 : 1681 1690.
3. Shepherd J, Blauw GJ PROSPER study group. et al. PROspective Study of Pravastatin in the Elderly at Risk. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): A randomized controlled trial. Lancet 2002 360 : 1623 1630.
4. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomized placebo-controlled trial. Lancet 2002 360 : 7 22 2002; 4:486-487.
5. Wagstaff LR, Mitton MW, Arvik BM et al. Statin-associated memory loss: Analysis of 60 case reports and review of the literature. Pharmacotherapy 2003 23 : 871 880.
6. Muldoon MF, Ryan CM, Sereika SM et al. Randomized trial of the effects of simvastatin on cognitive functioning in hypercholesterolemic adults. Am J Med 2004 117 : 823 829.
7. Evans MA, Golomb BA. Statin-associated adverse cognitive effects: Survey results from 171 patients. Pharmacotherapy 2009 29 : 800 811.
8. Algotsson A, Winblad B. Patients with Alzheimer's disease may be particularly susceptible to adverse effects of statins. Dement Geriatr Cogn Disord 2004 17 : 109 116.
9. Kiener PA, Davis PM, Murray JL et al. Stimulation of inflammatory responses in vitro and in vivo by lipophilic HMG-CoA reductase inhibitors. Int Immunopharmacol 2001 1 : 105 118.
10. Sparks DL, Connor DJ, Browne PJ et al. HMG-Co A reductase inhibitors (statins) in the treatment of Alzheimer's disease and why it would be ill-advise to use one that crosses the blood-brain barrier. J Nutr Health Aging 2002 6 : 324 331.